The EPS projection of Tenet Healthcare Corporation (NYSE:THC) for quarter ended 2016-09-30 is $0.39. Last week, the projection for EPS was $0.39 against target of $0.39, a month earlier. While 2-months ago, this projection was $0.39 versus forecast of $0.39a quarter months earlier, posting a deviation of 0%.
Tenet Healthcare Corporation (NYSE:THC) posted that 18 days earlier, the share price was revised 3 times on upside. In addition, negative revisions were 3.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 2. While in last 120 and 90 days, positive revisions were 4, and 4, correspondingly.
The per-share earnings downgrade for Tenet Healthcare Corporation (NYSE:THC) in the preceding 30 and 120 were 0 and 5. While in 60 and 90 days were 0, and 5, in that order.
Tenet Healthcare Corporation (NYSE:THC) EPS target was $0.39 for the quarter closed 1. It was based on 11 calls. As on 2016-05-02 the EPS was $0.45. The change was $0.12, posting a deviation of 36.36%. The price projections gave a standard deviation of 0.06.
Quarterly Sales Estimates
Tenet Healthcare Corporation (NYSE:THC) sales prediction for the fiscal 2017 stands at $5220.25 and the median estimate is at $5145.5. Almost 4 analysts gave sales target.
Among this, the highest sales estimate is $5524 while the lowest target is $5066 showing standard deviation of 206.756%.
As many as 4 analysts have positive sales targets revision while 4 reduced sales estimates, posting a deviation of 0%.
Last month, 4 experts have positive sales number revision. Also, 4 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast, posting a deviation of 0.178%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...